Unaudited Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2021	$ 366,327	$ 41	$ 413,967	$ (270)	$ (47,411)
Beginning balance (in shares) at Dec. 31, 2021		41,243,137
Exercise of common stock options	1		1
Exercise of common stock options (in shares)		7,405
Shares issued under employee stock purchase plan	307		307
Shares issued under employee stock purchase plan (in shares)		32,662
Vesting of restricted shares	712	$ 1	711
Vesting of restricted shares (in shares)		218,065
Stock-based compensation	8,402		8,402
Unrealized gain (loss) on available-for-sale securities, net	(1,637)			(1,637)
Net Income (Loss)	(30,298)				(30,298)
Ending balance at Jun. 30, 2022	343,814	$ 42	423,388	(1,907)	(77,709)
Ending balance (in shares) at Jun. 30, 2022		41,501,269
Beginning balance at Mar. 31, 2022	356,082	$ 41	418,429	(1,567)	(60,821)
Beginning balance (in shares) at Mar. 31, 2022		41,393,660
Exercise of common stock options (in shares)		1,000
Shares issued under employee stock purchase plan	307		307
Shares issued under employee stock purchase plan (in shares)		32,662
Vesting of restricted shares	209	$ 1	208
Vesting of restricted shares (in shares)		73,947
Stock-based compensation	4,444		4,444
Unrealized gain (loss) on available-for-sale securities, net	(340)			(340)
Net Income (Loss)	(16,888)				(16,888)
Ending balance at Jun. 30, 2022	343,814	$ 42	423,388	(1,907)	(77,709)
Ending balance (in shares) at Jun. 30, 2022		41,501,269
Beginning balance at Dec. 31, 2022	320,740	$ 42	432,703	(1,535)	(110,470)
Beginning balance (in shares) at Dec. 31, 2022		41,616,260
Exercise of common stock options	$ 1,580		1,580
Exercise of common stock options (in shares)	148,649	148,649
Shares issued under employee stock purchase plan	$ 528		528
Shares issued under employee stock purchase plan (in shares)		57,911
Vesting of restricted shares	139		139
Vesting of restricted shares (in shares)		44,716
Stock-based compensation	10,974		10,974
Unrealized gain (loss) on available-for-sale securities, net	475			475
Net Income (Loss)	(34,967)				(34,967)
Ending balance at Jun. 30, 2023	299,469	$ 42	445,924	(1,060)	(145,437)
Ending balance (in shares) at Jun. 30, 2023		41,867,536
Beginning balance at Mar. 31, 2023	311,264	$ 42	439,890	(739)	(127,929)
Beginning balance (in shares) at Mar. 31, 2023		41,802,807
Shares issued under employee stock purchase plan	528		528
Shares issued under employee stock purchase plan (in shares)		57,911
Vesting of restricted shares	5		5
Vesting of restricted shares (in shares)		6,818
Stock-based compensation	5,501		5,501
Unrealized gain (loss) on available-for-sale securities, net	(321)			(321)
Net Income (Loss)	(17,508)				(17,508)
Ending balance at Jun. 30, 2023	$ 299,469	$ 42	$ 445,924	$ (1,060)	$ (145,437)
Ending balance (in shares) at Jun. 30, 2023		41,867,536